Хайлтын үр дүнгүүд - Daan P. Hurkmans
- 8-н 1 - 8 үр дүнгүүдийг харуулж байна
-
1
Blood-based extracellular matrix biomarkers are correlated with clinical outcome after PD-1 inhibition in patients with metastatic melanoma -н Daan P. Hurkmans, Christina Jensen, Stijn L.W. Koolen, Joachim G.J.V. Aerts, M.A. Karsdal, Ron H.J. Mathijssen, Nicholas Willumsen
Хэвлэсэн 2020Artigo -
2
PD-L1/PD-1 expression and tumor-infiltrating lymphocytes in conjunctival melanoma -н Jinfeng Cao, Niels J. Brouwer, Kate Richards, Marina Marinkovic, Sjoerd G. van Duinen, Daan P. Hurkmans, Els M.E. Verdegaal, Ekaterina S. Jordanova, Martine J. Jager
Хэвлэсэн 2017Artigo -
3
Tumor mutational load, CD8+ T cells, expression of PD-L1 and HLA class I to guide immunotherapy decisions in NSCLC patients -н Daan P. Hurkmans, Merian E. Kuipers, Jasper Smit, Ronald van Marion, Ron H.J. Mathijssen, Piet E. Postmus, Pieter S. Hiemstra, Joachim G.J.V. Aerts, Jan H. von der Thüsen, Sjoerd H. van der Burg
Хэвлэсэн 2020Artigo -
4
CD45RA+CCR7− CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumab -н André Kunert, Edwin A. Basak, Daan P. Hurkmans, Hayri E. Balcıoğlu, Yarne Klaver, Mandy van Brakel, Astrid A. M. Oostvogels, C. B. H. W. Lamers, Sander Bins, Stijn L.W. Koolen, Astrid A.M. van der Veldt, Stefan Sleijfer, Ron H.J. Mathijssen, Joachim G.J.V. Aerts, Reno Debets
Хэвлэсэн 2019Artigo -
5
Granzyme B is correlated with clinical outcome after PD-1 blockade in patients with stage IV non-small-cell lung cancer -н Daan P. Hurkmans, Edwin A. Basak, Nina Schepers, Esther Oomen‐de Hoop, Cor H. van der Leest, Samira El Bouazzaoui, Sander Bins, Stijn L.W. Koolen, Stefan Sleijfer, Astrid A.M. van der Veldt, Reno Debets, Ron H. N. van Schaik, Joachim G.J.V. Aerts, Ron H.J. Mathijssen
Хэвлэсэн 2020Artigo -
6
Impact of Curcumin (with or without Piperine) on the Pharmacokinetics of Tamoxifen -н Koen G. A. M. Hussaarts, Daan P. Hurkmans, Esther Oomen–de Hoop, Leonie J. van Harten, Stan Berghuis, Robbert J. van Alphen, Leontine E.A.M.M. Spierings, Quirine C. van Rossum‐Schornagel, Mijntje B. Vastbinder, Ron H. N. van Schaik, Teun van Gelder, Agnes Jager, Roelof W. F. van Leeuwen, Ron H.J. Mathijssen
Хэвлэсэн 2019Artigo -
7
A prospective cohort study on the pharmacokinetics of nivolumab in metastatic non-small cell lung cancer, melanoma, and renal cell cancer patients -н Daan P. Hurkmans, Edwin A. Basak, Tanja van Dijk, Darlene Mercieca, Marco W.J. Schreurs, Annemarie Wijkhuijs, Sander Bins, Esther Oomen‐de Hoop, Reno Debets, Markus Joerger, Arlette E. Odink, Astrid A.M. van der Veldt, Cor H. van der Leest, Joachim G.J.V. Aerts, Ron H.J. Mathijssen, Stijn L.W. Koolen
Хэвлэсэн 2019Artigo -
8
Fibrotic activity quantified in serum by measurements of type III collagen pro-peptides can be used for prognosis across different solid tumor types -н Nicholas Willumsen, Christina Jensen, George Green, Neel I. Nissen, Jaclyn Neely, David M. Nelson, Rasmus S. Pedersen, Peder Frederiksen, Inna M. Chen, Mogens K. Boisen, Astrid Z. Johansen, Daniel H. Madsen, Inge Marie Svane, Allan Lipton, Kim Leitzel, Suhail M. Ali, Janine T. Erler, Daan P. Hurkmans, Ron H.J. Mathijssen, Joachim G.J.V. Aerts, Mohammed Eslam, Jacob George, Claus Christiansen, Mina J. Bissel, M.A. Karsdal
Хэвлэсэн 2022Revisão
Хайх хэрэгслүүд:
Холбогдох сэдвүүд
Internal medicine
Medicine
Cancer research
Oncology
Cancer
Immunotherapy
CD8
Immune system
Immunology
Melanoma
Nivolumab
Biochemistry
Granzyme
Immunohistochemistry
In vitro
Lung cancer
Perforin
Pharmacokinetics
Receptor
T cell
Adenocarcinoma
Antigen
Biology
Blockade
Breast cancer
CD28
Chemistry
Cohort
Curcumin
Cytotoxic T cell